Literature DB >> 16459345

Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.

Peter Gerber1, Armin Stucki, Fernando Acosta, Marianne Cottagnoud, Philippe Cottagnoud.   

Abstract

OBJECTIVES: To test the efficacy of daptomycin, a cyclic lipopeptide antibiotic, against a methicillin-susceptible Staphylococcus aureus strain in experimental rabbit meningitis and to determine its penetration into non-inflamed and inflamed meninges
RESULTS: Over a treatment period of 8 h, daptomycin (15 mg/kg) was significantly superior to the comparator regimen vancomycin (-4.54 +/- 1.12 log(10)/mL for daptomycin versus -3.43 +/- 1.17 log(10)/mL for vancomycin). Daptomycin managed to sterilize 6 out of 10 CSFs compared with 4 out of 10 for vancomycin. The penetration of daptomycin into inflamed meninges was approximately 5% and approximately 2% into non-inflamed meninges.
CONCLUSIONS: The superior bactericidal activity of daptomycin was confirmed in vivo and in time-killing assays in vitro.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16459345     DOI: 10.1093/jac/dkl007

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  16 in total

1.  Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis.

Authors:  Denis Grandgirard; Melchior Burri; Philipp Agyeman; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

2.  The Use of Daptomycin and Linezolid to Treat Vancomycin-Intermediate Staphylococcus haemolyticus Infection in a Premature Infant.

Authors:  Kalen B Porter; Bethany Lynch; Chitra S Mani
Journal:  J Pediatr Pharmacol Ther       Date:  2010-10

3.  Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall.

Authors:  A Stucki; M Cottagnoud; V Winkelmann; T Schaffner; P Cottagnoud
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

Review 4.  Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci.

Authors:  Ana Maria Rivera; Helen W Boucher
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

5.  Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia.

Authors:  Theodoros Kelesidis; Romney Humphries; Kevin Ward; Michael A Lewinski; Otto O Yang
Journal:  Diagn Microbiol Infect Dis       Date:  2011-08-19       Impact factor: 2.803

6.  Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline.

Authors:  Heather B Jaspan; Adam W Brothers; Angela J P Campbell; John K McGuire; Samuel R Browd; Thomas J Manley; Daniel Pak; Scott J Weissman
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

7.  Activity of daptomycin against Listeria monocytogenes isolates from cerebrospinal fluid.

Authors:  Lodewijk Spanjaard; Christina M J E Vandenbroucke-Grauls
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

Review 8.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

9.  Daptomycin versus vancomycin in treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model.

Authors:  Selin Bardak-Ozcem; Tuncer Turhan; Oguz Resat Sipahi; Bilgin Arda; Husnu Pullukcu; Tansu Yamazhan; Meltem Isikgoz-Tasbakan; Hilal Sipahi; Sercan Ulusoy
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

10.  Daptomycin in experimental murine pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Mark S Rouse; Cheol-In Kang; Diederik van de Beek; James M Steckelberg; Robin Patel
Journal:  BMC Infect Dis       Date:  2009-04-30       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.